Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48 - PubMed (original) (raw)

Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48

A Curtin et al. Acta Diabetol. 1996 Sep.

Abstract

The role of the intestine in cholesterol metabolism in human diabetes is unclear, although abnormalities have been demonstrated in cholesterol synthesis and absorption in diabetic animals. This study examines the relationship between fasting and post-prandial apolipoprotein B-48 in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Eight type 2 diabetic patients and ten healthy non-diabetic control subjects were given a high-fat meal (1300 kcal), and the triglyceride-rich lipoprotein fraction was isolated by ultracentrifugation (d < 1.006 g/ml) from fasting and post-prandial plasma. Apolipoprotein B-48 and apo B-100 were separated on 4%-15% gradient gels and quantified by densitometric scanning with reference to a purified low-density lipoprotein (LDL) apo B-100 preparation. Diabetic patients had significantly higher concentrations of apo B-48 and apo B-100 in both the fasting (P < 0.05) and post-prandial (P < 0.001) triglyceride-rich lipoprotein samples compared with non-diabetic subjects. The diabetic patients also exhibited a significantly different post-prandial profile for apo B-48 and apo B-100, with a prolonged increase and a later post-prandial peak, than the non-diabetic subjects (P < 0.01). These results suggest that the raised fasting triglyceride-rich lipoproteins, often found in diabetes, are associated with apo B-48 and may be derived from increased intestinal chylomicron production. The post-prandial pattern suggests an abnormality in intestinal production as well as hepatic clearance of apo B-48 in type 2 diabetes.

PubMed Disclaimer

Similar articles

• Intestinally derived lipoprotein particles in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia.
  Curtin A, Deegan P, Owens D, Collins P, Johnson A, Tomkin GH. Curtin A, et al. Acta Diabetol. 1995 Dec;32(4):244-50. doi: 10.1007/BF00576257. Acta Diabetol. 1995. PMID: 8750763
• The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
  Taggart C, Gibney J, Owens D, Collins P, Johnson A, Tomkin GH. Taggart C, et al. Diabet Med. 1997 Dec;14(12):1051-8. doi: 10.1002/(SICI)1096-9136(199712)14:12<1051::AID-DIA507>3.0.CO;2-Q. Diabet Med. 1997. PMID: 9455933
• Alterations in apolipoprotein B-48 in the postprandial state in NIDDM.
  Curtin A, Deegan P, Owens D, Collins P, Johnson A, Tomkin GH. Curtin A, et al. Diabetologia. 1994 Dec;37(12):1259-64. doi: 10.1007/BF00399800. Diabetologia. 1994. PMID: 7895956 Clinical Trial.
• Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
  Oscarsson J, Hurt-Camejo E. Oscarsson J, et al. Lipids Health Dis. 2017 Aug 10;16(1):149. doi: 10.1186/s12944-017-0541-3. Lipids Health Dis. 2017. PMID: 28797250 Free PMC article. Review.
• Lipoprotein production by the heart: a novel pathway of triglyceride export from cardiomyocytes.
  Nielsen LB. Nielsen LB. Scand J Clin Lab Invest Suppl. 2002;237:35-40. doi: 10.1080/003655102762377475. Scand J Clin Lab Invest Suppl. 2002. PMID: 12570165 Review.

Cited by

• Intestinal lipid absorption and transport in type 2 diabetes.
  Vergès B. Vergès B. Diabetologia. 2022 Oct;65(10):1587-1600. doi: 10.1007/s00125-022-05765-8. Epub 2022 Jul 30. Diabetologia. 2022. PMID: 35908083 Review.
• Postprandial dyslipidemia in insulin resistant states in adolescent populations.
  Higgins V, Adeli K. Higgins V, et al. J Biomed Res. 2020 Jan 30;34(5):328-342. doi: 10.7555/JBR.34.20190094. J Biomed Res. 2020. PMID: 32934193 Free PMC article.
• Potential of Glucagon-Like Peptide 1 as a Regulator of Impaired Cholesterol Metabolism in the Brain.
  Kim YK, Song J. Kim YK, et al. Adv Nutr. 2020 Nov 16;11(6):1686-1695. doi: 10.1093/advances/nmaa080. Adv Nutr. 2020. PMID: 32627818 Free PMC article. Review.
• Effect of sitagliptin on energy metabolism and brown adipose tissue in overweight individuals with prediabetes: a randomised placebo-controlled trial.
  Nahon KJ, Doornink F, Straat ME, Botani K, Martinez-Tellez B, Abreu-Vieira G, van Klinken JB, Voortman GJ, Friesema ECH, Ruiz JR, van Velden FHP, de Geus-Oei LF, Smit F, Pereira Arias-Bouda LM, Berbée JFP, Jazet IM, Boon MR, Rensen PCN. Nahon KJ, et al. Diabetologia. 2018 Nov;61(11):2386-2397. doi: 10.1007/s00125-018-4716-x. Epub 2018 Aug 25. Diabetologia. 2018. PMID: 30145664 Free PMC article. Clinical Trial.
• Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial).
  Masuda D, Kobayashi T, Sairyou M, Hanada H, Ohama T, Koseki M, Nishida M, Maeda N, Kihara S, Minami T, Yanagi K, Sakata Y, Yamashita S. Masuda D, et al. J Atheroscler Thromb. 2018 Jun 1;25(6):512-520. doi: 10.5551/jat.41343. Epub 2017 Dec 2. J Atheroscler Thromb. 2018. PMID: 29199201 Free PMC article.

References

1. 1. Anal Biochem. 1978 Jun 15;87(1):206-10 - PubMed
2. 1. Diabetes. 1990 May;39(5):626-33 - PubMed
3. 1. J Clin Invest. 1990 Mar;85(3):883-92 - PubMed
4. 1. Diabetologia. 1994 Mar;37(3):238-46 - PubMed
5. 1. Cell. 1987 Sep 11;50(6):831-40 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information